Attention Impairment in Patients of Schizophrenia

Background: Cognitive impairment has a high prevalence in Schizophrenia and has been linked to functional outcome. To date statistically significant effects of medication on cognition in mood disorder trials and in schizophrenia do not necessarily translate to clinically meaningful effects.  Objectives: To study the socio-demographic profiles of Schizophrenic patients and normal control and to assess and compare cognitive functions among patients of Schizophrenia disorder and normal control. Material and Methods:  100 schizophrenic patients as per ICD 10 who came to Psychiatry OPD and 100 normal controls of Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India were recruited for the study. Results: Schizophrenic patients were found to be having significant level of cognitive impairment as compared to normal controls.